LifeLabs Buys Centogene's Canadian Genetic Testing Business | GenomeWeb

NEW YORK (GenomeWeb News) – LifeLabs Medical Laboratory Services today announced it has acquired the Canadian business of Centogene for an undisclosed amount.

Germany-based Centogene provides genetic testing for inherited diseases and performs testing for a number of genetic centers in Canada. During the next few months, Centogene's test portfolio will be transitioned to Toronto-based LifeLabs, and Centogene's services will continue uninterrupted to clients in Canada, LifeLabs said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.